In conclusion, FOXM1 plays an important role in the development of ovarian cancer as well as in drug resistance in this disease, indicating that inhibition of FOXM1 activity may play a role in ovarian cancer therapy. This evidence concerns the gene FOXM1 and ovarian cancer.